Patient Safety and Protocol Integrity in EBO2 Therapy

In recent years, a concerning trend has emerged within the regenerative medicine space. Some providers performing Extracorporeal Blood Oxygenation and Ozonation (EBO2) are presenting blood clots formed during treatment as proof that the therapy is “working.” However, this interpretation reflects a serious misunderstanding, and in some cases, misrepresentation, of how extracorporeal therapies are designed to function. More importantly, it raises critical concerns about patient safety and informed consent.

EBO2 is an advanced extracorporeal procedure in which blood is temporarily removed from the body, exposed to oxygen and ozone, and then safely returned through a closed-loop system. Because blood interacts with artificial surfaces such as tubing and filters, the body’s natural clotting cascade is immediately activated.

For this reason, strict anticoagulation protocols are essential.

Established guidelines from international ozone therapy authorities recommend:

• Pre-flushing the system with heparin (2,500–5,000 IU)
• Maintaining a maximum total dose of up to 10,000 IU during treatment
• Administering additional heparin if any signs of clotting occur

These measures are not optional, they are fundamental to ensuring safe and effective treatment.

Some marketing narratives suggest that clots seen in EBO2 tubing represent:

• Toxins
• Plaque
• Or harmful debris being removed from the bloodstream

This is incorrect and potentially dangerous.

Clots formed in the extracorporeal circuit are not pre-existing substances from the patient’s body. Instead, they are:

• Iatrogenic (caused by the procedure itself)
• The direct result of inadequate anticoagulation

In other words, these clots form during the treatment, not before it.

When visible clotting occurs during EBO2, it signals multiple issues:

• Insufficient initial anticoagulation
• Inadequate monitoring throughout the procedure
• Failure to intervene promptly when clotting begins

Heparin, the primary anticoagulant used, has a relatively short half-life. Therefore, without careful monitoring and timely re-dosing, clot formation becomes predictable rather than rare.

In comparable extracorporeal therapies, such as ECMO, any clot formation is treated as a serious complication, requiring immediate correction. It is never considered a positive outcome.

Presenting procedural complications as therapeutic benefits creates a serious ethical concern. Patients deserve accurate information when making decisions about their care.

If clot formation is framed as a sign of success:

• Patients may be misled about the true safety profile of the treatment
• Informed consent is compromised
• Providers may unintentionally lower their vigilance regarding proper protocols

Additionally, significant clot formation may suggest broader anticoagulation issues, which could introduce unnecessary risk if not properly managed.

EBO2 is a promising and legitimate therapy when performed correctly. However, its effectiveness depends entirely on adherence to established medical protocols.

As providers of advanced therapies, we must:

• Prioritize patient safety above marketing narratives
• Maintain strict protocol integrity
• Communicate with transparency and accuracy

Reframing complications as benefits not only puts patients at risk, it also undermines the credibility of regenerative and functional medicine as a whole.

When considering EBO2 therapy, it is appropriate to ask:

• What anticoagulation protocol is used?
• How is clotting monitored during treatment?
• What steps are taken if clotting is observed?

Clear, confident answers to these questions reflect a commitment to safe, evidence-informed care.

When performed properly, EBO2 therapy should not produce visible clot formation.

Clots are not a sign of detoxification, they are a sign that protocol adjustments are needed immediately.

The future of regenerative medicine depends on clinical integrity, patient trust, and scientific accuracy. While compelling visuals may attract attention, they should never replace sound medical practice.

At its core, effective care is not about what looks dramatic, it’s about what is safe, precise, and grounded in evidence. Patients deserve nothing less.